Search - tctmd.com

Displaying 681 - 700 of 1164

Sort: Relevancy | Date

An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention

Presentation AHA 2016

PIONEER Trial: An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy

Presenter: Michael Gibson

November 15, 2016

Presentation AHA 2016

Arterial Revascularization Trial (ART)

Presenter: David P. Taggart

November 15, 2016

News Conference News AHA 2016

The ART of CABG: Bilateral Technique Associated With Similar Outcomes as Single Graft at 5 Years

Yael L. Maxwell

November 14, 2016

News Conference News AHA 2016

Estudio ART sobre CABG: La Técnica Bilateral se Asocia a Resultados Similares a los del Injerto Único a los 5 Años

Yael L. Maxwell

November 14, 2016

News Conference News AHA 2016

CABG 的 ART：双侧技术与单一移植 5 年结果类似

Yael L. Maxwell

November 14, 2016

News Industry News

Trial Results Suggest That Drug-Eluting Stents Are Acceptable Alternative To Open Heart Surgery For Select Patients With Left Main Coronary Artery Disease

October 31, 2016

Presentation TCT 2016

NOBLE: A Prospective, Randomized Trial Comparing Biolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease

Presenter: Martin B. Leon, Keith G. Oldroyd, Evald H. Christiansen

October 31, 2016

News Conference News TCT 2016

EXCEL 和 NOBLE：左主干 PCI/CABG 的选择结果相悖

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

EXCEL y NOBLE: Los Resultados Contrarios Plantean un Dilema a la Hora de Elegir entre PCI y CABG en el Manejo de la Enfermedad de Tronco Coronario Izdo.

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

Michael O'Riordan

October 31, 2016

Presentation TCT 2016

EXCEL: A Prospective, Randomized Trial Comparing Everolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease

Presenter: Martin B. Leon, Keith G. Oldroyd, Gregg W. Stone

October 31, 2016

Presentation Stanford Coronary Physiology Conference 2016

Will FFR-Directed PCI Be Better Than CABG? Update on the FAME 3 trial

Presenter: William F. Fearon

October 28, 2016

News Daily News

Medication Compliance May Impact Revascularization Outcomes

L.A. McKeown

October 25, 2016

News Daily News

New-Onset Atrial Fibrillation Post-CABG More Common, Lasts Longer in Men Than in Women

Shelley Wood

October 19, 2016

News Industry News

Edwards INSPIRIS RESILIA Valve Receives CE Mark

September 29, 2016

News Features

Grumbling Over Bundling: Cardiologists React Warily to Plans for Lump-Sum Payments for Cardiac Care

Caitlin E. Cox

September 23, 2016

News Conference News ESC 2016

BASKET-SAVAGE: DES Reign for Saphenous Vein Graft PCI Amid Declining Use

Shelley Wood

August 31, 2016

News Conference News ESC 2016

STICH Analysis by Age Shows Benefit of CABG in Ischemic Heart Failure Across the Decades

Shelley Wood

August 29, 2016

Presentation ESC 2016

10-year outcomes of coronary artery bypass grafting vs medical therapy according to age: An update from the STICH trial

Presenter: Eric Velazquez

August 29, 2016

Presentation

Coronary Perforation During PCI in the United Kingdom Between 2006 and 2013

Presenter: Tim Kinnaird

August 04, 2016

Advertisement

PIONEER Trial: An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy

Arterial Revascularization Trial (ART)

The ART of CABG: Bilateral Technique Associated With Similar Outcomes as Single Graft at 5 Years

Estudio ART sobre CABG: La Técnica Bilateral se Asocia a Resultados Similares a los del Injerto Único a los 5 Años

CABG 的 ART：双侧技术与单一移植 5 年结果类似

Trial Results Suggest That Drug-Eluting Stents Are Acceptable Alternative To Open Heart Surgery For Select Patients With Left Main Coronary Artery Disease

NOBLE: A Prospective, Randomized Trial Comparing Biolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease

EXCEL 和 NOBLE：左主干 PCI/CABG 的选择结果相悖

EXCEL y NOBLE: Los Resultados Contrarios Plantean un Dilema a la Hora de Elegir entre PCI y CABG en el Manejo de la Enfermedad de Tronco Coronario Izdo.

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

EXCEL: A Prospective, Randomized Trial Comparing Everolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease

Will FFR-Directed PCI Be Better Than CABG? Update on the FAME 3 trial

Medication Compliance May Impact Revascularization Outcomes

New-Onset Atrial Fibrillation Post-CABG More Common, Lasts Longer in Men Than in Women

Edwards INSPIRIS RESILIA Valve Receives CE Mark

Grumbling Over Bundling: Cardiologists React Warily to Plans for Lump-Sum Payments for Cardiac Care

BASKET-SAVAGE: DES Reign for Saphenous Vein Graft PCI Amid Declining Use

STICH Analysis by Age Shows Benefit of CABG in Ischemic Heart Failure Across the Decades

10-year outcomes of coronary artery bypass grafting vs medical therapy according to age: An update from the STICH trial

Coronary Perforation During PCI in the United Kingdom Between 2006 and 2013

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content